|

VMD-102 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Single agent

Pipeline

Phase 1/2: 1

Top Sponsors

  • VM Discovery, Inc.1

Indications

  • Liver Disease1
  • Metastatic Uveal Melanoma1
  • Renal Cell Carcinoma (RCC)1
  • Nonsmall-cell Lung Cancer1
  • Hepatocellular Carcinoma (HCC)1

Scottsdale, Arizona1 trial

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

HonorHealth Research Institute

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.